about
Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In VivoInfluence of Successful Chronic Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir on Warfarin Dosing Requirements in Four Veterans.Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.Significance of functional disease-causal/susceptible variants identified by whole-genome analyses for the understanding of human diseases.Increased hope following successful treatment for hepatitis C infection.Viral Oncology: Molecular Biology and Pathogenesis.Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.
P2860
Q38933599-B20AC9DF-6352-4238-A820-3907BE7D8976Q40419531-1099FC56-A3D9-465A-BF84-070BB8D17D86Q40466282-2903DD44-4055-428E-832C-09F643CD2D42Q45372289-821AA193-8F72-4521-9CDE-A74ABA1FB8E2Q47109078-B70E2D21-6801-4471-A41C-CF32BA165F62Q47566260-E1111E55-18FE-4764-B576-22851BB91F1BQ47571734-AC0C45AE-CE69-4137-A3A1-B6ADA72DAA78Q52597394-37B5A89E-2AFC-44D6-BBF5-08546B83A1AA
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatitis C-A clinical review.
@en
type
label
Hepatitis C-A clinical review.
@en
prefLabel
Hepatitis C-A clinical review.
@en
P2093
P2860
P356
P1476
Hepatitis C-A clinical review.
@en
P2093
Ira M Jacobson
Lan S Wang
Lionel S D'Souza
P2860
P304
P356
10.1002/JMV.24554
P577
2016-04-20T00:00:00Z